Search results
Found 8461 matches for
As the world anxiously awaits COVID-19 vaccines, people working in healthcare settings remain at risk of infection from COVID-19. The Pakistani arm of COPCOV, the global study to test if hydroxychloroquine or chloroquine can prevent COVID-19 in healthcare workers, has begun to enrol participants at Aga Khan University, joining sites in the UK and Thailand.
Clinical Trials Support Group (CTSG)
The Clinical Trials Support Group (CTSG) supports investigators conducting research for the MORU Tropical Health Network and in collaboration with MORU sister units in Vietnam and Kenya – an international endeavour both in Thailand and across Southeast Asia and Africa
Clinical Therapeutics Unit (CTU)
The Clinical Therapeutics Unit (CTU) conducts clinical studies on the treatment of uncomplicated malaria and analyses and models pathological responses in malaria, G6PD deficiency, vivax relapse and anti-infective drug pharmacometric and pharmacodynamics data.
Epidemiology
MORU Epidemiology studies the factors that contribute to the risk of different diseases and how to reduce those risks. The research portfolio includes clinical studies, descriptive epidemiology, and statistical and mathematical modelling of human diseases in South and Southeast Asia and Africa with a focus on malaria, dengue, novel pathogens and environmental health.
Bioethics & Engagement
Paying attention to the public and communities is essential to make our programmes ethical and trustworthy, to maximise their success and impact.
Mathematical and Economic Modelling (MAEMOD)
The Mathematical and Economic MODelling (MAEMOD) Department’s main research focus is mathematical and economic models supporting investigations into the transmission, control and elimination of tropical diseases.
Clinical Pharmacology
Established in 2003 to meet a need for accurate, sensitive antimalarial drug measurements in the biological fluids of clinical trials patients, MORU’s Department of Clinical Pharmacology is now one of the world’s leading laboratories for antimalarial drug pharmacology.
Microbiology
Opened in 1986, the Microbiology Department conducts research on: melioidosis, scrub typhus and other rickettsial infections; antimicrobial resistance; leptospirosis; the epidemiology of infectious diseases; sepsis and severe sepsis; the evaluation of diagnostic tests; and the immunology and cell biology of infectious diseases.
Malaria & Critical illness
The aim of the Malaria & Critical Illness Department at MORU is to improve health through research that addresses threats arising from malaria for billions of people who live in malaria endemic zones around the globe. Our research focuses on the diagnosis, pathophysiology, treatment including the raising issue of drug resistance, prevention and elimination of malaria